Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
News for Sonendo, Inc. (SONX) centers on its activities as a commercial-stage medical technology and dental technology company. Sonendo develops and manufactures the GentleWave System, a platform for treating tooth decay and performing root canal therapy by cleaning and disinfecting microscopic spaces within teeth without removing tooth structure. Company news often reiterates this focus on saving teeth from tooth decay and improving clinical outcomes in endodontic care.
Investors and dental professionals following Sonendo’s news can expect regular updates on financial performance, including revenue from GentleWave consoles, procedure instruments and other products, as well as disclosures on gross margin, operating loss, adjusted EBITDA loss and free cash flow burn. The company has reported on a strategic reset and restructuring efforts aimed at stabilizing revenue, expanding margins and reducing operating expenses and cash burn.
Sonendo’s news flow also covers product and technology developments, such as the launch of ProControl for the GentleWave G4 System. This software update is described as enabling optimized cleaning of complex anatomy, increased procedure efficiency and the ability to adjust procedure fluid concentration levels when using the CleanFlow procedure instrument. Such announcements highlight the company’s focus on evolving its GentleWave platform and supporting personalized treatment in endodontics.
Additional news items may include capital-raising and financing transactions, such as private placements of common stock and amendments to credit facilities, as well as strategic transactions like the Asset Purchase Agreement to acquire Biolase assets through a bankruptcy court process and updates on related patent litigation. Leadership and organizational updates, including changes in operational roles, also appear in Sonendo’s press releases. For a consolidated view of these developments, this news page aggregates Sonendo’s public announcements and market-facing communications.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Sonendo, a dental technology company, announces its sponsorship of Save Your Tooth Month 2023, promoting the benefits of endodontic treatment. This initiative, organized by the American Association of Endodontists (AAE), involves various activities throughout May. Sonendo has been a sponsor since 2020 and will continue to support the campaign until at least 2024. Additionally, Sonendo will participate in the 2023 AAE Annual Meeting in Chicago from May 3-6, showcasing its GentleWave G4 System and proprietary CleanFlow Technology. The company has committed to donating $50,000 to the AAE's Foundation for Endodontics for research and education. Sonendo focuses on saving teeth from decay through its GentleWave® System, offering improved clinical outcomes with less invasive procedures.
Sonendo, a dental technology company, announced it will report its financial results for Q1 2023 after market close on May 9, 2023. A conference call will follow at 1:30 PM PT. Investors can access the call by dialing (833) 470-1428 or via the company's website. Sonendo is known for its GentleWave® System, an innovative treatment for tooth decay, aiming to improve clinical outcomes while minimizing pain and preserving tooth structure. The company also owns TDO® Software, enhancing dental practice efficiency. This announcement reaffirms Sonendo’s commitment to transparency and investor engagement.
Sonendo, Inc. (NYSE: SONX) announced leadership changes, effective June 1, 2023, as COO Andrew Kirkpatrick steps down to pursue new opportunities. To enhance operational efficiency, John McGaugh joins as Vice President of Operations, bringing over 20 years of experience, including roles at Abbott Vascular and Boston Scientific. The company aims to improve its gross margin profile, a critical initiative highlighted by President and CEO Bjarne Bergheim. Additionally, Kevin Yein has been promoted to Vice President of R&D, recognized for his contributions to product innovations like the GentleWave G4 System. Both leaders will report to Bergheim and are expected to drive growth and operational enhancements within the company.